Cassava Sciences | PTIE - Market Capitalization

Stock Price
1.18
Daily Change
-0.06 -4.84%
Monthly
-32.95%
Yearly
-43.54%
Q2 Forecast
1.16

Cassava Sciences reported $53.6M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Cara Therapeutics USD 366M 338M Sep/2025
Cassava Sciences USD 96M 45M Dec/2025
Eisai JPY 1.33T 22.44B May/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Geron USD 946M 9M May/2026
J&J USD 579.15B 78.91B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 232.75B 75B May/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 147.4B 6.42B May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025